Inhibition of cerebral vasoconstriction by dantrolene and nimodipine.
D000818:Animals; D001488:Basilar Artery / Q000187:drug effects* / Q000502:physiology; D003620:Dantrolene / Q000494:pharmacology*; D005263:Femoral Artery / Q000187:drug effects / Q000502:physiology; D008297:Male; D009125:Muscle Relaxants, Central / Q000494:pharmacology*; D009131:Muscle, Smooth, Vascular / Q000187:drug effects / Q000378:metabolism; D009553:Nimodipine / Q000494:pharmacology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D019837:Ryanodine Receptor Calcium Release Channel / Q000378:metabolism; D046509:Tissue Culture Techniques; D014661:Vasoconstriction / Q000187:drug effects*; D014665:Vasodilator Agents / Q000494:pharmacology*
D009125:Muscle Relaxants, Central; D019837:Ryanodine Receptor Calcium Release Channel; D014665:Vasodilator Agents; D009553:Nimodipine; D003620:Dantrolene